Official 2024 U.S. DOL Form 5500 summary for Acella Pharmaceuticals, LLC (Acella Pharmaceuticals, LLC 401(k) Profit Sharing · EIN 26-1193374 · PN 001): $31.59M net assets, 551 active participants, and $79.83 per $10,000 (79.83 bps).
| Plan Sponsor | Acella Pharmaceuticals, LLC |
|---|---|
| Filing Identifier | Acella Pharmaceuticals, LLC 401(k) Profit Sharing · EIN 26-1193374 · PN 001 |
| Plan Category & State | 401(k) Defined Contribution (GA) |
| Asset-Size Peer Cohort | $25M-$100M |
| Plan Net Assets (2024) | $31.59M |
| Active Participants | 551 |
| Direct Admin Fee Rate | $79.83 per $10,000 (79.83 bps) |
| Cohort Peer Median | $19.23 per $10,000 (19.23 bps) |
| Primary Recordkeeper / Provider | Transamerica |
| Schedule H Line 4a Remittance | Timely Employer Remittance (0 reported on Line 4a) |
Browse all 78,373 plans & Schedule C vendors · Methodology · Meru AI